Quarterly report pursuant to Section 13 or 15(d)

Note 3 - Merger with CLS Labs (Details) - Business Acquisition, Pro Forma Information

v3.3.1.900
Note 3 - Merger with CLS Labs (Details) - Business Acquisition, Pro Forma Information - USD ($)
3 Months Ended 6 Months Ended
Nov. 30, 2014
Nov. 30, 2014
Business Acquisition, Pro Forma Information [Abstract]    
Total revenue $ 0 $ 0
Net loss attributable to CLS Holdings USA, Inc. $ (192,172) $ (320,829)
Basic net income (loss) per common share $ (0.01) $ (0.02)
Diluted net income (loss) per common share $ (0.01) $ (0.02)
Weighted average shares - basic 15,000,000 15,000,000
Weighted average shares - diluted 15,000,000 15,000,000